BIG NEWS: Peer Reviewed Study Demonstrates Efficacy of Ivermectin in Prophylactis and Treatment of COVID — And It Won’t Kill You!

 

A peer-reviewed study found that ivermectin can end the COVID pandemic. The medicine was found to “significantly reduces the risk of contracting the deadly respiratory disease when used regularly.”

Like hydroxychloroquine the drug is well known to doctors. It has been used as an antiparasitic.

The peer-reviewed study on its effectiveness was published in the American Journal of Therapeutics.

And the good news is that ivermectin won’t kill you!

The The Weather Channel thought this was important enough to publish:

A peer-reviewed research has claimed that global ivermectin use can end the COVID-19 pandemic, as the medicine significantly reduces the risk of contracting the deadly respiratory disease when used regularly.

The common antiparasitic ivermectin is being touted as a miracle cure for COVID-19 by doctors and campaigners the world over.

Peer reviewed by medical experts that included three US government senior scientists and published in the American Journal of Therapeutics, the research is the most comprehensive review of the available data taken from clinical, in vitro, animal, and real-world studies.

Led by the Front Line COVID-19 Critical Care Alliance (FLCCC), a group of medical and scientific experts reviewed published peer-reviewed studies, manuscripts, expert meta-analyses, and epidemiological analyses of regions with ivermectin distribution efforts all showing that ivermectin is an effective prophylaxis and treatment for COVID-19.

“We did the work that the medical authorities failed to do, we conducted the most comprehensive review of the available data on ivermectin,” said Pierre Kory, MD, president and chief medical officer of the FLCCC. “We applied the gold standard to qualify the data reviewed before concluding that ivermectin can end this pandemic.”

A focus of the manuscript was on the 27 controlled trials available in January 2021, 15 of which were randomised controlled trials (RCT’s).